Business | Press Trust of India | Wednesday November 18, 2015
Zydus Cadila has received US health regulator's nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high fat levels in body due to diabetes, obesity and sedentary habits.
www.ndtv.com/business